Zurich Cantonal Bank
PBYI icon

Zurich Cantonal Bank’s Puma Biotechnology PBYI Stock Holding History

Zurich Cantonal Bank’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed – – 2811
2021
Q4 		$0 Sell
1
-1,863
-100% -$8.09K ﹤0.01% 2931
2021
Q3 		$13K Hold
1,864
– – ﹤0.01% 2805
2021
Q2 		$17K Sell
1,864
-3,040
-62% -$30.8K ﹤0.01% 2586
2021
Q1 		$48K Hold
4,904
– – ﹤0.01% 2399
2020
Q4 		$50K Hold
4,904
– – ﹤0.01% 2435
2020
Q3 		$49K Hold
4,904
– – ﹤0.01% 2261
2020
Q2 		$51K Buy
4,904
+3,104
+172% +$32.1K ﹤0.01% 2206
2020
Q1 		$15K Sell
1,800
-899
-33% -$8.73K ﹤0.01% 2412
2019
Q4 		$24K Hold
2,699
– – ﹤0.01% 2461
2019
Q3 		$29K Hold
2,699
– – ﹤0.01% 2319
2019
Q2 		$34K Sell
2,699
-200
-7% -$4.61K ﹤0.01% 2272
2019
Q1 		$112K Hold
2,899
– – ﹤0.01% 1513
2018
Q4 		$59K Hold
2,899
– – ﹤0.01% 1932
2018
Q3 		$133K Hold
2,899
– – ﹤0.01% 1547
2018
Q2 		$171K Hold
2,899
– – ﹤0.01% 1336
2018
Q1 		$197K Sell
2,899
-400
-12% -$30K ﹤0.01% 1210
2017
Q4 		$326K Buy
3,299
+740
+29% +$82.8K ﹤0.01% 963
2017
Q3 		$306K Buy
2,559
+1,500
+142% +$140K ﹤0.01% 913
2017
Q2 		$93K Buy
1,059
+263
+33% +$14.7K ﹤0.01% 1413
2017
Q1 		$30K Hold
796
– – ﹤0.01% 2112
2016
Q4 		$24K Hold
796
– – ﹤0.01% 2189
2016
Q3 		$53K Buy
796
+130
+20% +$6.57K ﹤0.01% 1605
2016
Q2 		$20K Hold
666
– – ﹤0.01% 2112
2016
Q1 		$20K Hold
666
– – ﹤0.01% 2058
2015
Q4 		$52K Sell
666
-1,291
-66% -$101K ﹤0.01% 1432
2015
Q3 		$147K Hold
1,957
– – ﹤0.01% 953
2015
Q2 		$228K Buy
1,957
+1,827
+1,405% +$331K ﹤0.01% 925
2015
Q1 		$31K Buy
+130
New +$27.8K ﹤0.01% 1031

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Zurich Cantonal Bank's PBYI Position: Q1 2022 in Review

Zurich Cantonal Bank sold out of Puma Biotechnology (PBYI) in Q1 2022, closing a stake of 1 share.

Zurich Cantonal Bank first reported a position in PBYI in Q1 2015 and held it in 28 quarters. The position peaked at $326K in Q4 2017. 104 funds tracked by Wall St. Rank hold PBYI as of Q1 2022.

  • Zurich Cantonal Bank reported no remaining Puma Biotechnology position as of Q1 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1 Puma Biotechnology share in Q1 2022.
  • Zurich Cantonal Bank first reported a position in Puma Biotechnology in Q1 2015 and held it in 28 quarters.
  • Zurich Cantonal Bank's Puma Biotechnology position peaked at $326K in Q4 2017.
  • 104 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2022.

Based on Zurich Cantonal Bank's 13F filing for Q1 2022, filed 21 Apr 2022.